Logo for Bicara Therapeutics Inc

Bicara Therapeutics Investor Relations Material

Latest events

Logo for Bicara Therapeutics Inc

Status Update

Bicara Therapeutics
Logo for Bicara Therapeutics

Status Update

1 Jun, 2025
Logo for Bicara Therapeutics

Q1 2025

13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Bicara Therapeutics Inc

Access all reports
Bicara Therapeutics Inc. is a biopharmaceutical company focused on developing innovative immuno-oncology therapies for cancer treatment. The company specializes in creating biologics that combine tumor-targeting properties with immune modulation to improve treatment outcomes for patients with advanced or resistant cancers. Bicara’s research and development efforts are geared toward creating therapies that harness the body’s immune system to selectively target and combat cancer cells. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.